| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.041 | 0.4 |